Adaptive Biotechnologies Corp (ADPT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Sales | 26,058 | 22,138 | 12,666 | 0 | 17,188 |
| Cost of Goods | 5,601 | 5,734 | 4,988 | N/A | 5,360 |
| Gross Profit | 20,457 | 16,404 | 7,678 | N/A | 11,828 |
| Operating Expenses | 39,111 | 33,243 | 28,711 | 0 | 21,349 |
| Operating Income | -18,053 | -16,105 | -20,045 | N/A | -9,161 |
| Other Income | 4,103 | 446 | 1,659 | 0 | 869 |
| Pre-tax Income | -13,950 | -15,659 | -18,386 | 0 | -8,292 |
| Net Income Continuous | -13,950 | -15,659 | -18,386 | N/A | -8,292 |
| Net Income | $-13,950 | $-15,659 | $-18,386 | $N/A | $-8,292 |
| EPS Basic Total Ops | -0.11 | -1.23 | -1.45 | N/A | -0.66 |
| EPS Basic Continuous Ops | -0.11 | -1.18 | -1.43 | N/A | -0.66 |
| EPS Diluted Total Ops | -0.11 | -1.23 | -1.45 | N/A | -0.66 |
| EPS Diluted Continuous Ops | -0.11 | -1.18 | -1.43 | N/A | -0.66 |
| EBITDA(a) | $-17,627 | $-15,513 | $-18,880 | $N/A | $-8,061 |